最新ニュース Equinor (NYSE:EQNR) 株価情報

Equinor

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2023 (53% liquids) and ended 2023 with 5.2 billion barrels of proven reserves (49% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Equinor ASA

Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) shares were climbing on Wednesday after the company reported <a href="https://www.benzinga.com/news/earnings/24/12/42303322/okta-q3-earnings-revenue-beat-eps-beat-strong-guidance-shares-surge">upbeat third-quarter results</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<h1 class="wp-block-heading">BMO Capital Markets On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585beadcb5a482000151d18b/keith-bachman">Analyst Keith Bachman</a> reiterated a Market Perform rating while lifting the price target from $103 to $105.
Okta generated revenue growth of 14% year-on-year, exceeded consensus of 11%, Bachman said in a note. "We believe Okta executed well against a macro that remains characterized by ongoing scrutiny and software rationalization, consistent with the past few quarters," he added.
The company provided a conservative guidance for fiscal 2026, which "sets an achievable bar," particularly for revenue growth of 7%, the analyst stated. "While this quarter is a step in the right direction, we continue to harbor concerns on long-term product expansion and competition," he further wrote.
<h1 class="wp-block-heading">Needham On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> maintained a Buy rating while raising the price target from $100 to $115.
Okta&#8217;s results exhibited "improved execution, with solid performance from Large Customers, Partners, and New Products," Cikos said. The quarter indicated "early signs of product adoption," with the company's offering significantly expanding in recent quarters, as well as easing headwinds from the "COVID cohort," he added.
Investors may be "caught off-guard" by the company's preliminary guidance of revenues between $2.77 billion and $2.78 billion in fiscal 2026, which missed the consensus estimate of $2.81 billion, the analyst stated. "However, we see the preliminary outlook as just that — preliminary; which is conservative based on management&#8217;s typical approach to guidance — setting for cRPO," he further wrote.
<h1 class="wp-block-heading">Stifel On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6022b60ca6fe6f0001873d54/adam-borg">Analyst Adam Borg</a> reiterated a Buy rating while raising the price target from $108 to $115.
Okta delivered strong results for the third quarter with all key metrics above guidance, "although several metrics including NRR and new logo additions remain softer," Borg said. The company's fourth-quarter guidance was above expectations, and its full-year guidance was raised by more than the beat, he added.
Okta&#8217;s 2026 outlook "will prove conservative as the year plays out," the analyst stated. "Given Okta&#8217;s broadening workforce/customer identity portfolio, the company plans to build out GTM specializations next year to reinvigorate growth, moves we support," he further wrote.
<h1 class="wp-block-heading">Piper Sandler On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Analyst Rob Owens</a> reaffirmed a Neutral rating while raising the price target from $85 to $90.
Okta's subscription revenue of $651 million represented a deceleration to 14% year-on-year growth "but beat our estimate of $635M," Owens said. The company's total revenue came in higher than the midpoint of guidance by 2.5%, "slightly above last quarter&#8217;s beat but below the one-year average," he added.
The company reported cRPO of $2.062 billion, which topped the guidance midpoint by $75 million, the analyst stated. "Commentary surrounding down-sell pressures on renewals potentially easing in 2H&#8217;26 was encouraging, but clarity on the sustainable growth remains hazy," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Goldman Sachs On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/589dc33e43eaaa000122c59a/gabriela-borges">Analyst Gabriela Borges</a> maintained a Buy rating while raising the price target from $97 to $107.
Okta reported its quarterly revenues, EBIT and cRPO higher than consensus by 2%, 15% and 4%, respectively, Borges said. "New products represented 15% of bookings, up from last year as Okta has an expanded product portfolio, she added.
Its fourth-quarter revenue and EBIT guidance came in 3% and 10% above the Street, while cRPO guidance is 1% high, the analyst stated. Although management's initial fiscal 2026 revenue guidance is 1% below the Street, "we believe is consistent with investor expectations at +7% yoy," she further wrote.
<h1 class="wp-block-heading">Guggenheim Securities On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">Analyst John DiFucci</a> maintained a Buy rating and price target of $130.
Okta "easily exceeded" the consensus estimates and guided above the Street, DiFucci said. He added, however, that the company's preliminary fiscal 2026 revenue growth guidance of 7% came in below consensus of 9%.
"Although management noted that it was no longer incorporating additional conservatism into guidance due to the incident of October 2023, we estimate that a meaningful amount of conservatism is still included in preliminary FY26 numbers," the analyst wrote. 
Management indicated continued seeing pressure on seat number in deals, "but this is at least partially being offset by growth in new product sales," he further stated.
<h1 class="wp-block-heading">RBC Capital Markets On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">Analyst Matthew Hedberg</a> had an Outperform rating and a price target of $101.
"Okta delivered another solid quarter relative to expectations," Hedberg wrote in a note, as well as that cRPO grew by 13%, higher than guidance of 9%.
The company's fourth-quarter cRPO guidance of 9% year-on-year "looks conservative," the analyst stated. "The FY/26 early look includes a sales org shift to specialized selling, a disappointing/conservative 7% revenue growth vs prior consensus at 9.6% and at least 22%/24% OI/FCF margins that was in-line with consensus," he further wrote.
<h1 class="wp-block-heading">Oppenheimer On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5937f6b185b07a0001ac364f/ittai-kidron">Analyst Ittai Kidron</a> reiterated an Outperform rating and price target of $125.
Okta's third-quarter results were strong and fourth-quarter guidance came above consensus, Kidron said. "Large customer trends and product cross-sell activity remain healthy and are offsetting ongoing macro headwinds on new customer adds (+150 QoQ) and existing customer seat/license/MAU expansion," he added.
While management maintained a cautious tone regarding the macro environment, they were increasingly positive on product and cross-sell opportunities, the analyst stated. "Consistent with this, Okta is investing (new products, GSI/channel, etc.), and evolving its GTM (specialization), which bodes well for continued near-term upside driven by existing customers," he further wrote.
<h1 class="wp-block-heading">KeyBanc Capital Markets On Okta</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62eacb8a9bab060001dbd41a/eric-heath">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62eacb8a9bab060001dbd41a/eric-heath">Eric Heath</a> reiterated a Sector Weight rating on the stock.
Okta's beat on cRPO, revenue, and margins was "solid," Heath said. The company guided its fourth-quarter cRPO $26 million above consensus versus guiding below in the prior two quarters, he added.
Management does not expect the outperformance from the initial revenue guide for fiscal 2025 to repeat in fiscal 2026, the analyst stated. "Assuming typical seasonal cRPO growth and consistent cRPO coverage, it may suggest a similar degree of upside," he further wrote.
OKTA Price Action: Shares of Okta had risen by 4.39% to $85.22 at the time of publication on Wednesday.
Read More: • <a href="https://www.benzinga.com/24/12/42306809/palantir-salesforce-okta-meta-and-tesla-why-these-5-stocks-are-on-investors-radars-today">Palantir, Salesforce, Okta, Meta, And Tesla: Why These 5 Stocks Are On Investors&#8217; Radars Today</a>
Photo: Shutterstock

Analyst Color

Earnings

Earnings Beats

Guidance

Price Target

Reiteration

Analyst Ratings

Movers

Tech

Trading Ideas

OKTA

Okta Posts Q3 Beat, Guidance Miss: Analyst Says 'Sustainable Growth Remains Hazy'

WIIM

SAP shares are trading higher in possible sympathy with Salesforce, which rose after reporting quarterly earnings.

<a href="https://www.youtube.com/watch?v=f-KMvpiUAbk" title="https://www.youtube.com/watch?v=f-KMvpiUAbk">https://www.youtube.com/watch?v=f-KMvpiUAbk</a>

News

Federal Reserve

$BTC

Fed Chair Powell Says Central Bank Cannot Take Debt And Deficits Into Account In Setting Rates; Needs To Focus On Inflation; The Fed Is Far From A Situation Of Fiscal Dominance, Uses Its Tools To Achieve Mandate On Inflation And Jobs; Bitcoin Is Used As A Speculative Asset; It Is A Competitor With Gold Not The U.S. Dollar; Low And Moderate Income Families In The U.S. Are Under Pressure Even Though Aggregate Numbers Are Strong

PYPL

PayPal shares are trading higher. The company presented at the UBS Global Technology Conference today.

JP Morgan analyst Doug Anmuth named Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) the top pick following a solid start to the early holiday shopping season.
Early holiday 2024 data points suggest solid U.S. e-commerce growth, with third-party estimates indicating U.S. e-commerce Cyber Week sales growth mainly in line with Anmuth&#8217;s projected +7.5% fourth-quarter U.S. e-commerce sales growth (vs. +9.8% in fourth-quarter of 2023).
Adobe and Mastercard data suggest growth exceeded the analyst&#8217;s +7.5% estimate on Black Friday, and Adobe indicated in-line growth trends during Cyber Monday and Cyber Week.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42265010/amazon-and-walmart-dominate-black-friday-as-online-sales-soar-146" rel="noreferrer noopener">Amazon And Walmart Dominate Black Friday As Online Sales Soar 14.6%</a>
Salesforce data implies growth in line with Anmuth&#8217;s expectations during Black Friday and Cyber Week but with softer Cyber Monday trends. Amazon announced its Black Friday Week and Cyber Monday holiday shopping period was once again its biggest ever, with record sales, record number of items sold, and customers saving billions of dollars.
Holiday 2024 marks the shortest since 2019 (27 days between Thanksgiving and Christmas), but earlier promotions and deeper markdowns should continue to drive solid growth, the analyst said.
Consumers face still-elevated inflation and interest rates, though macro headwinds are broadly stable compared to a year ago.&nbsp;&nbsp;
The analyst projected U.S. e-commerce penetration at 24.5% of adjusted retail sales this holiday season, +119bps above 23.3% in 2023.
Longer-term, Anmuth noted U.S. e-commerce penetration of adjusted retail sales could nearly double from ~22% today to 40%+ supported by gains across large, underpenetrated categories such as CPG (including Grocery), Apparel &amp; Accessories, &amp; Furniture, Appliances, &amp; Equipment.
Amazon maintains a leading ~45% share of U.S. e-commerce. Anmuth noted it is well positioned during the holiday season, with strong momentum from early holiday promotions, SD1D delivery, regionalization, expansion of the Prime ecosystem, and competitive prices.
Profitero suggested Amazon prices at ~14% average discount to competitors.&nbsp;&nbsp;
Anmuth projected fourth-quarter retail revenue (non-AWS) growth of +8.9%.
The analyst modeled Amazon&#8217;s +7.6 % U.S. GMV (ex Physical Stores) growth, which is in line with his estimated +7.5 % U.S. e-commerce growth and 46.7% U.S. e-commerce share in the fourth quarter (+2bps).
<h2 class="wp-block-heading">Is Amazon A Good Stock To Buy?</h2>
An investor or trader's decision to buy or sell a stock is unique to their time horizon and risk tolerance. Many typical investors evaluate earnings growth and valuation on a particular stock before making a decision. 
For example, for Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), you'll notice that earnings in its last quarter grew 25.44% <a href="https://www.benzinga.com/quote/AMZN/earnings">source</a>. As an investor, you'll want to decide whether that's better or worse than what you'd like to see among stocks in your portfolio. 
On the valuation side, Amazon.com's price to earnings ratio &#8211; a measure of how much an investor pays for the company's earnings &#8211; is compressed 50.9% in the current quarter when compared with last year. That places it above similar businesses Alibaba Gr Hldgs, PDD Holdings, MercadoLibre in its sector. You'll need to decide whether that makes it more or less attractive based on how you think the company will perform over time.
There are many different valuation metrics that may help you make a decision. Find more on <a href="https://www.benzinga.com/quote/AMZN">Amazon.com's quote page</a>, or if you'd like a deeper dive in an advanced program, try <a href="https://pro.benzinga.com">Benzinga PRO</a> for free.
Price Action: AMZN stock is up 2.35% at $218.47 at last check Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42300462/amazon-web-services-mix-of-marvell-and-trainium-still-trails-nvidia-analyst" target="_blank" rel="noreferrer noopener">Amazon Web Services Mix Of Marvell And Trainium Still Trails Nvidia: Analyst</a></li>
</ul>
Photo by jamesteohart via Shutterstock

AMZN

Amazon Emerges As Top Analyst Pick In Holiday Season

Shares of Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) are trading lower Wednesday after CEO Jared Isaacman announced his nomination by President-elect Donald Trump to serve as NASA Administrator. Here&#8217;s <a href="https://www.benzinga.com/general/space/24/09/40842633/public-company-ceo-goes-to-space-is-there-risk-for-shareholders-when-billionaires-pursue-space-drea">what you need to know.</a>
What To Know: Isaacman, the founder and CEO of Shift4, confirmed the nomination on social media X (formerly known as Twitter), writing, "I am honored to receive President Trump's nomination to serve as the next Administrator of NASA." He also emphasized his belief in the potential of space exploration to drive advancements in manufacturing, biotechnology and energy.
Isaacman's increasing involvement in space-related ventures may have drawn attention. Recently, he participated in SpaceX's Polaris Dawn mission, where he conducted a private spacewalk. These activities have potentially raised questions about his availability to lead the company and the risks posed to shareholders by his dual focus.
The news comes at a time when Shift4 has been reliant on Isaacman's leadership for its growth. Investors appear concerned about the potential impact of his departure, with today's selloff reflecting uncertainty about the company's future direction.
Shares of Shift4 have traded in a 52-week range of $42.91 to $92.30. Further updates on Isaacman's confirmation process and the company's plans for leadership may further influence market sentiment.
FOUR Price Action: Shift4 Payments shares were down 10.9% at $101.71 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1733167806337199"><img loading="lazy" decoding="async" width="1024" height="543" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04134201/four-1024x543.png" alt="" class="wp-image-677131" style="width:486px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04134201/four-1024x543.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04134201/four-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04134201/four-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04134201/four.png 1150w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42323152/nasdaq-surges-150-points-ism-services-pmi-falls-in-november">Nasdaq Surges 150 Points; ISM Services PMI Falls In November</a></li>
</ul>
Image via Shutterstock.

FOUR

Shift4 Payments Stock Drops After CEO Jared Isaacman's NASA Nomination: What's Going On?

Fed Chair Powell Says U.S. Budget Is On An Unsustainable Path; Revenue And Spending Need To Be Better Aligned

ALIT

Alight Chairman William P. Foley II Confirms Cannae's Sale Of 12M Alight Shares To Address Liquidity Needs, Reaffirms Confidence In Alight's Long-Term Growth Prospects; Do Not Have Any Expectations For Additional Sales Of Alight Shares For Foreseeable Future From Cannae

GDDY

GoDaddy shares are trading higher after RBC Capital reiterated an Outperform rating on the stock and raised its price target from $190 to $230.

Fed Chair Powell Says Fed Does Not Comment On Dollar Policy, Which Is The Responsibility Of The Treasury

NICE

NICE shares are trading higher after the company announced an 80% year-over-year increase in digital for retailers over black Friday and cyber Monday.

PLTR

Palantir shares are trading lower in possible reaction to a report suggesting OpenAI will work with Anduril Industries to add its technology to drone defense systems.

Fed Chair Powell Says Regarding Tariffs, So Much Is Unknown The Fed Cannot Start Making Policy In Response; The Fed Does Not Have An Institutional View On The Proper Level Of Tariffs Or Immigration; Higher Immigration Is Part Of The Reason Growth Was Strong In 2023

Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) shares are moving higher on Wednesday after Truist Securities analyst Jake Bartlett maintained a Buy rating on Chipotle and raised the price target from <a href="https://www.benzinga.com/insights/analyst-ratings/24/12/42317311/in-depth-examination-of-20-analyst-recommendations-for-chipotle-mexican-grill">$72 to $74</a>. 
What To Know: In his note, the analyst pointed out that Chipotle has begun raising prices at certain locations, a move he believes is being made from a position of strength.
Tthe Mexican restaurant chain has increased prices by about 2% on proteins at approximately 20% of United States locations. The analyst noted that Chipotle typically implements price increases over several weeks and therefore expects additional price hikes at other locations.
The analyst highlighted that a 50bps increase in traffic in November suggests the price hike was initiated from a strong position. Chipotle previously reported a 4% growth in traffic for September, up from 2.5% in July, a trend that continued into October.
Related Link: <a href="https://www.benzinga.com/24/12/42321349/drakes-legal-fight-involving-kendrick-lamar-takes-center-stage-and-so-do-their-mega-mansions">Drake&#8217;s Legal Fight Involving Kendrick Lamar Takes Center Stage – And So Do Their Mega-Mansions</a>
CMG Price Action: At the time of writing, Chipotle stock is trading 4.61% higher at $63.75, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock.

What's Going On With Chipotle Mexican Grill Stock Wednesday?

Nano Nuclear Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares are trading lower by 2.37% to $25.98 during Wednesday&#8217;s session. The company <a href="https://www.benzinga.com/pressreleases/24/12/g42314037/nano-nuclear-energy-inc-and-u-s-department-of-energy-doe-idaho-operations-office-sign-mou-to-site-">earlier announced</a> a Memorandum of Understanding (MOU) with the U.S. Department of Energy&#8217;s Idaho Operations Office to explore siting, construction and operation of its proprietary ‘ZEUS' and ‘ODIN' microreactors at the Idaho National Laboratory (INL).
What To Know: NNE says these microreactors aim to deliver clean energy solutions for remote and industrial uses, supporting U.S. energy security and climate goals.
The partnership will focus on site evaluations, Nuclear Regulatory Commission (NRC) licensing, and the development of operational and safety plans, including hazardous material management and emergency planning. 
Both parties will bear their own costs, with the collaboration emphasizing compliance with the National Environmental Policy Act (NEPA) and other regulations.
The MOU, valid for five years with a renewal option, leverages INL&#8217;s infrastructure and expertise to progress the reactors toward demonstration and deployment. NANO Nuclear leaders highlighted the agreement as a significant step in advancing innovative nuclear technologies to strengthen energy resilience and sustainability.
Read Also: <a href="https://www.benzinga.com/tech/24/12/42321266/meta-joins-big-techs-shift-to-nuclear-power-for-ai-ambitions">Meta Joins Big Tech&#8217;s Shift To Nuclear Power For AI Ambitions</a>
<h2 class="wp-block-heading">How To Buy NVAX Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Nano Nuclear Energy&#8217;s case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NNE has a 52-week high of $37.50 and a 52-week low of $3.25.

What's Going On With Nano Nuclear Energy (NNE) Stock?

Fed Chair Powell Says Fed Is Trying To Be In A Middle Place Where Policy Is Less Restrictive So Inflation Can Fall, But Not Damage Labor Market; Likely That Lower Survey Response Levels Has Increased Volatility In Estimates Of Labor Market Data

<a href="https://www.wsj.com/tech/ai/openai-enters-silicon-valleys-hot-new-business-war-7beccf6e?mod=latest_headlines">https://www.wsj.com/tech/ai/openai-enters-silicon-valleys-hot-new-business-war-7beccf6e?mod=latest_headlines</a>
OpenAI, the artificial intelligence company behind <a href="https://www.wsj.com/tech/personal-tech/ai-chatbots-chatgpt-gemini-copilot-meta-c6835d9d?mod=article_inline">ChatGPT</a>, is getting into the business of war.
The world's most valuable AI company has agreed to work with Anduril Industries, a leading defense-tech startup, to add its technology to systems the U.S. military uses to counter drone attacks. The partnership, which the companies announced Wednesday, marks OpenAI's deepest involvement yet with the Defense Department and its first tie-up with a commercial weapons maker.

MSFT

"OpenAI Enters Silicon Valley's Hot New Business: War; The Leading AI Company Has Agreed To Put Its Powerful Tech In Anduril's Drone Defense Systems" - WSJ

On Wednesday, Relmada Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) announced a preplanned interim analysis of the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42312084/relmada-therapeutics-reports-that-data-monitoring-committee-dmc-assessment-indicates-that-the-phas" rel="noreferrer noopener">Reliance II Phase 3 study</a>.
Reliance II is designed to evaluate REL-1017 as an adjunctive treatment for major depressive disorder (MDD), to be used in combination with other approved anti-depressants.
The Independent Data Monitoring Committee (DMC) analysis indicated that the Reliance II Phase 3 study is futile and unlikely to meet the primary efficacy endpoint with statistical significance.
No new safety signals were reported.
&#8220;We are disappointed with the outcome of this interim analysis,&#8221; said&nbsp;Sergio Traversa, Chief Executive Officer of Relmada. &#8220;Based on these results, Relmada will evaluate the full dataset to determine next steps for the REL-1017 program. The Company will continue to advance the Phase 1 study of REL-P11, an investigational agent for the treatment of metabolic disease, currently in a Phase 1 first-in-human study. We are grateful to the investigative sites and patients who participated in the REL-1017 program.&#8221;
In July 2021, Relmada acquired the development and commercial rights to a novel psilocybin and derivatives program. Psilocybin has neuroplastogen effects that have the potential to ameliorate neurodegenerative conditions.
Relmada identified the potential to use low-dose psilocybin to treat metabolic diseases and published the data at the American Society for the Study of Liver Disease.
Last year, Relmada Therapeutics released efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3 trial (Study 310) of REL-1017 in patients with&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/23/09/34768110/relmada-therapeutics-lead-candidate-shows-promise-in-pivotal-depression-study" rel="noreferrer noopener">Major Depressive Disorder (MDD)</a>.
Patients treated daily with REL-1017 for up to one year experienced rapid, clinically meaningful, and sustained improvements in depressive symptoms and associated functional impairment.&nbsp;
In November,&nbsp;Relmada Therapeutics initiated dosing in a Phase 1 SAD study of REL-P11, an investigational agent for metabolic disease. Phase 2a proof-of-concept study is expected to begin in the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41968869/relmada-therapeutics-initiates-phase-1-dosing-with-rel-p11-for-metabolic-disease" rel="noreferrer noopener">first half of 2025</a>.
Price Action: RLMD stock is down 75.4% at $0.68 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/12/42320501/edwards-lifesciences-outlines-vision-for-growth-at-investor-conference" target="_blank" rel="noreferrer noopener">Edwards Lifesciences Outlines Vision For Growth At Investor Conference</a></li>
</ul>
Photo via Shutterstock

Biotech

Health Care

General

RLMD

Relmada Therapeutics Stock Plummets Losing 80% Value - Here's Why

In the latest quarter, 5 analysts provided ratings for Axos Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AX#NYSE">AX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $81.4, a high estimate of $91.00, and a low estimate of $74.00. This current average has increased by 5.71% from the previous average price target of $77.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1733338902_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of Axos Financial by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$91.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$74.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Announces</td>
<td>Buy</td>
<td>$82.00</td>
<td>-</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Axos Financial. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Axos Financial compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Axos Financial's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Axos Financial's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Axos Financial analyst ratings.</a>
<h2>Get to Know Axos Financial Better</h2>
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.
<h3>Unraveling the Financial Story of Axos Financial</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Axos Financial's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 30.91% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Axos Financial's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 35.51%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Axos Financial's ROE excels beyond industry benchmarks, reaching 4.78%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Axos Financial's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.48%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.17.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Axos Financial: Insights From 5 Financial Analysts

12 analysts have shared their evaluations of Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Coherent, revealing an average target of $113.5, a high estimate of $135.00, and a low estimate of $86.00. This upward trend is apparent, with the current average reflecting a 22.77% increase from the previous average price target of $92.45.
<img src="https://www.benzinga.com/files/images/story/2024/1733338891_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Coherent by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Notter</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$135.00</td>
<td>-</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$120.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Ruben Roy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Richard Shannon</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$106.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Mehdi Hosseini</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$125.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Dave Kang</td>
<td>B. Riley Securities</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$86.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$108.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Coherent. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coherent compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coherent's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COHR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coherent analyst ratings.</a>
<h2>Unveiling the Story Behind Coherent</h2>
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
<h3>Unraveling the Financial Story of Coherent</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Coherent's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 28.02% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Coherent's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.44%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coherent's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.11%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.04%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Coherent's debt-to-equity ratio surpasses industry norms, standing at 0.76. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COHR

Key Takeaways From Coherent Analyst Ratings

Equinor trims 20% of staff in renewable energy unit - Reuters

Barclays upgraded Equinor (EQNR) to Overweight from Equal Weight with an unchanged price target of NOK 400. The market appears too negative on Euro...

Equinor upgraded to Overweight from Equal Weight at Barclays

The Gold Standard Oil And Gas Companies

Equinor upgraded at Barclays as market too negative on European natural gas

Berenberg analyst James Carmichael upgraded Equinor (EQNR) to Buy from Hold with a price target of NOK 325, up from NOK 290. European gas prices ha...

Equinor upgraded to Buy from Hold at Berenberg

Equinor raised to Buy at Berenberg, seeing strength in natural gas prices

Latest data shows the largest indicative borrow rate increases among liquid option names include: SPIRIT AIRLINES INC. (SAVEQ) 382.54% +72.80, Lumi...

Largest borrow rate increases among liquid names

SFL Corporation: Still Solid Despite Offshore Drilling Challenges - Buy

Equinor ASA (EQNR) has released an update. Equinor ASA has executed significant share buy-backs, acquiring 1.75 million shares from November 25 to ...

Equinor ASA Boosts Shareholder Value with Buy-Back

Protean Funds Scandinavia AB November 2024 Partner Letter

AMKAF

AMKBF

AMKBY

AMTX

CIVI

CRGY

CTRA

EQNR

ERIC

ERIXF

FANG

GNGBF

GNGBY

HXGBF

HXGBY

KOYJF

LAZR

LYSFF

LYSFY

MHGVY

MNHVF

NTNOF

ODFJF

OKLO

RSLBF

SAVA

SHEL

SKBSY

SKSBF

SOUN

STOHF

Press Releases

Equinor to commence third tranche of the 2024 share buy-back programme

Equinor ASA: Ex. dividend first quarter 2024 today - Oslo Børs

Equinor ASA: Announcement of cash dividend per share in NOK for first quarter 2024

Equinor ASA  - Key information relating to full redemption of bond loan

Equinor acquires a 9.8% minority stake in Ørsted

Equinor third quarter 2024 results

Equinor ASA: Key information relating to cash dividend for third quarter 2024

Equinor to commence fourth tranche of the share buy-back programme for 2024

Equinor ASA: Ex. dividend second quarter 2024 today - Oslo Børs

Equinor ASA: Announcement of cash dividend per share in NOK for second quarter 2024

Chevron

Ecopetrol S.A. American Depositary Shares

Ecopetrol

Occidental Petroleum Corporation Common Stock

Occidental Petroleum

Petroleo Brasileiro S.A.- Petrobras Common Stock

Petrobras Brasileiro

Petroleo Brasileiro S.A.- Petrobras American Depositary Shares

Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares)

Shell

TotalEnergies

Exxon Mobil

Morgan Stanley

TD Cowen

PARR

VNOM

Shares of oil and gas companies are lower ahead of OPEC's supply decision on Thursday. The commodity may be falling due to ongoing conflict in the Middle East.

Comments

Equinor

ニュース

最新ニュース Equinor (NYSE:EQNR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル